Ribi Immunochem (ribi) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ribi Immunochem (ribi)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Kevin Ameling who wrote (44)	12/2/1997 2:03:00 PM
From: Bill Tomko	Read Replies (1) of 92

Anyone investing in RIBI should read the current issue of Forbes Page 254 SmithKline's promising vaccines. and the editorial in the Jan. 10 1997 issue of the New England Journal of Medicne re adjuvants. Likewise follow the BIOMF trials and related delay.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next